Could a 7-Day pill blast beat a 14-Day regimen for stomach bug?
NCT ID NCT07352098
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a 7-day high-dose vonoprazan-amoxicillin treatment to a standard 14-day regimen for eradicating H. pylori, a common stomach bacteria linked to ulcers and cancer. About 290 adults with confirmed infection will be randomly assigned to one of the two groups. The goal is to see if the shorter course works just as well with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vonoprazan and amoxicillin
- What this could lead to
- If successful, this could offer a shorter, more convenient treatment for H. pylori infection, potentially improving patient adherence and reducing side effects.
- What could go wrong
- This is an early-stage trial with only 290 participants, so results may not apply to everyone. The higher dose could also increase the risk of side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kashi Prefecture Hospital of Traditional Chinese Medicine
Kashgar, Xinjiang, 844000, China